Thus, inhibition upstream to mTOR in the PI3K-Akt pathway might be expected to enhance mTOR inhibition and to exert an anti-tumor effect [17, 39–46, 48, 49, 53]. This evidence concerns the gene PIK3CA and neoplasm.